BioPlus Acquisition Corp.

Status: Pre-IPO
U=S+W/3 W=S@11.50
IPO Proceeds, $M $220.00M
IPO Date *
CEO Ross Haghighat; J. Leighton Read, M.D.
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences

IPO Geography Global
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Geography TBD
Deal Sector TBD
SEC Filings www.sec.gov
BIOS BIOS.U BIOS.W

Not listed



Sign up for Free Trial

No credit card required

Sign in for more data on BioPlus Acquisition Corp.:

  • 7 directors & officers
  • 1 filings and events
  • 1 underwriters